What reduction in cardiovascular death does the content claim from the Pioneer 6 trial?

McCall McPhersonFounder, Modern Thyroid Clinic.

Revolutionary GLP-1 Treatment: Cut Heart Disease Risk by 51%!

28 Oct 2024 · 1 min

Watch on YouTube

0:35

Short YouTube video commentary by McCall McPherson about cardiovascular protection from GLP-1 therapies. The speaker claims GLP-1 treatments (citing the Pioneer 6 trial) reduce risk of cardiovascular death by 51% and emphasizes cardiovascular disease as the leading cause of death.

Questions this video answers

51% reduction (claims GLP-1 therapies reduce cardiovascular death by 51%, citing the Pioneer 6 trial).

Chapters

Next, like cardiovascular protection. So we talked about this in our other episodes, but cardiovascular disease is what kills. Almost like most of us. It kills more people than all forms of cancer combined. There is no cardiovascular disease treatment that reduces your risk of cardiovascular death 51%. Because that's what GLPs do. Yeah, that was the Pioneer 6 trial. If you want to look it up, 51% less. Basically, you're. If you are going to die, you are likely going to die of a cardiovascular event. That's all of us. So if you're on a GLP, you're 51% less likely to die.